shigella
Showing 1 - 7 of 7
Enterics for Global Health (EFGH)
Recruiting
- Shigella
- +2 more
-
Dhaka, Bangladesh
- +32 more
Sep 18, 2023
Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)
Recruiting
- Shigella
- SF2a-TT15 Shigella Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Completed
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Apr 27, 2021
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Terminated
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore Center for Vaccine Development
Apr 27, 2021
Shigella Trial in Baltimore (CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a)
Terminated
- Shigella
- CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
-
Baltimore, Maryland
- +1 more
Apr 27, 2021
Multidrug Resistant Shigella Infection in Bangladesh
Unknown status
- Diarrhea
- Shigella
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Jan 25, 2019
Dysentery, Shigella, Diarrhea Trial in Bangkok (Part 1/Arm 1 of Study: WRSS1 vaccine, Part 1/Arm 2 of Study: Placebo vaccine,
Completed
- Dysentery
- +2 more
- Part 1/Arm 1 of Study: WRSS1 vaccine
- +3 more
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Oct 10, 2018